Internal Medicine, Pulmonary Disease · Birmingham, AL
NPI
1669413688
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
737 services
Medicare patients, 2024
326
Average age 71
Drug cost, 2024
$674K
1,573 prescriptions
Company payments, 2025
$1,538
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia Patterson was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 250 times for 198 patients. In total Patricia Patterson billed 737 services in 15 codes, and Medicare paid $33K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 250 | 198 | $11.37 | $2,842 |
| 99214 Office E&M - Established | Facility | 166 | 129 | $66.98 | $11K |
| 99204 Office E&M - New | Facility | 52 | 52 | $83.44 | $4,339 |
| 95806 Sleep Study | Facility | 50 | 49 | $26.96 | $1,348 |
| 95810 Sleep Study | Facility | 50 | 50 | $79.30 | $3,965 |
| 95811 Sleep Study | Facility | 49 | 49 | $82.70 | $4,052 |
| 99203 Office E&M - New | Facility | 28 | 28 | $54.26 | $1,519 |
| 99213 Office E&M - Established | Facility | 22 | 20 | $38.82 | $854 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 20 | 17 | $11.48 | $230 |
| 99214 Office E&M - Established | Office | 16 | 14 | $77.75 | $1,244 |
| 95976 Electrical Nerve Conductivity | Facility | 14 | 14 | $27.97 | $392 |
By year: 2022 $39K for 552 services; 2023 $34K for 492 services; 2024 $33K for 737 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia Patterson prescribed most often to Medicare patients was Clonazepam, with 229 prescriptions and refills. In total Patricia Patterson wrote 1,573 Medicare prescriptions that cost $674K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 229 | 267 | 35 | $753 |
| Modafinil Generic | 220 | 264 | 39 | $23K |
| Gabapentin Generic | 136 | 221 | 30 | $1,401 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 118 | 118 | 18 | $5,191 |
| Belsomra Suvorexant | 97 | 103 | 21 | $42K |
| Armodafinil Generic | 95 | 117 | 14 | $9,109 |
| Eszopiclone Generic | 74 | 82 | 18 | $1,102 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 73 | 73 | 12 | $5,192 |
| Trazodone Hcl Generic | 59 | 112 | 21 | $572 |
| Doxepin Hcl Generic | 46 | 67 | 11 | $1,830 |
| Wakix Pitolisant Hcl | 43 | 43 | Under 11 | $525K |
| Methylphenidate Hcl Generic | 42 | 45 | Under 11 | $754 |
| Methylphenidate Er Methylphenidate Hcl | 31 | 31 | Under 11 | $1,119 |
| Zolpidem Tartrate Generic | 29 | 29 | Under 11 | $193 |
| Sunosi Solriamfetol Hcl | 28 | 28 | Under 11 | $23K |
Brand drugs: 223 claims; generic drugs: 1,350 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia Patterson $1,538 ($1,538 in general payments such as food, travel and fees) from 3 companies. The largest payer was Inspire Medical Systems, Inc. with $1,357.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.